Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.82M Buy
+1,195,142
New +$6.61M 0.03% 344
2025
Q4
Sell
-2,534,230
Closed -$7.73M 688
2025
Q3
$7.73M Hold
2,534,230
0.04% 305
2025
Q2
$6.08M Hold
2,534,230
0.04% 322
2025
Q1
$4.89M Hold
2,534,230
0.03% 334
2024
Q4
$13M Buy
2,534,230
+341,431
+16% +$2.1M 0.07% 225
2024
Q3
$13M Buy
2,192,799
+139,340
+7% +$826K 0.07% 235
2024
Q2
$10.1M Buy
+2,053,459
New +$10.6M 0.06% 251
2023
Q1
Sell
-164,558
Closed -$851K 879
2022
Q4
$851K Sell
164,558
-992
-0.6% -$5.45K 0.01% 734
2022
Q3
$1.02M Buy
+165,550
New +$895K 0.01% 699

Other funds holding ANNX

Candriam SCA's ANNX Position: Q2 2026 in Review

Candriam SCA opened a new position in Annexon (ANNX) in Q2 2026: 1,195,142 shares worth $6.82M. The stake represents 0.03% of the portfolio and ranks #344 among its holdings. This is a return to the name: Candriam SCA previously reported a position in ANNX as recently as Q3 2025.

Candriam SCA first reported a position in ANNX in Q3 2022 and has held it in 9 quarters since. The position peaked at $13M in Q4 2024. 217 funds tracked by Wall St. Rank hold ANNX as of Q2 2026.

  • Candriam SCA held 1,195,142 shares of Annexon worth $6.82M as of Q2 2026.
  • Annexon was a new Candriam SCA position in Q2 2026.
  • Annexon made up 0.03% of Candriam SCA's portfolio in Q2 2026, its #344 holding.
  • Candriam SCA first reported a position in Annexon in Q3 2022 and has held it in 9 quarters since.
  • Candriam SCA's Annexon position peaked at $13M in Q4 2024.
  • 217 funds tracked by Wall St. Rank held Annexon as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.